Ulcerative Colitis Resource Center

Ulcerative Colitis Resource Center

Issue: February 2021
Source: Healio Interview
Disclosures: Caldera reports no relevant financial disclosures.
December 29, 2020
1 min watch
Save

VIDEO: Benefit of COVID-19 vaccine outweighs risks in IBD patients

Issue: February 2021
Source: Healio Interview
Disclosures: Caldera reports no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this exclusive video, Freddy Caldera, DO, MS, assistant professor of medicine in the division of gastroenterology and hepatology at the University of Wisconsin School of Medicine and Public Health, spoke about the two recent COVID-19 vaccines that have been authorized for emergency use.

Caldera said if a patient with inflammatory bowel disease fits in the current vaccine allocations, they should receive the vaccine despite any fears of its efficacy in IBD. He said more research will need to be done to determine if IBD patients will benefit from booster shots. Similarly, pregnant women should so the same.

The benefit of getting the vaccine outweighs the risk for side effects from the vaccine, according to Caldera.